Topic
medicine-approval
1 stories related to this topic, newest first.
world4 hrs agoUpdated
NICE approves teplizumab for some NHS patients in England and Wales
The National Institute for Health and Care Excellence granted approval on Tuesday for teplizumab to treat stage 2 type 1 diabetes. The drug delays symptomatic onset by up to three years in adults and children aged eight and older.